Nano One Renews At-The-Market Equity Program

Executive Summary

• Nano One Materials Corp. has entered into an equity distribution agreement with Canaccord Genuity Corp. and Roth Canada, Inc. to renew its at-the-market (ATM) equity issuance program.
• The new program allows the company to distribute up to C$20,000,000 of common shares, subject to Toronto Stock Exchange approval.
• The ATM program is intended to provide flexible, cost-effective capital to support the final stages of the Candiac scale-up and commercialization efforts, complementing existing non-dilutive government support.

Key Details

• Transaction Type: Renewal of At-the-Market (ATM) Equity Issuance Program.
• Agents: Canaccord Genuity Corp. and Roth Canada, Inc.
• Maximum Aggregate Proceeds: Up to C$20,000,000 of Common Shares.
• Pricing Mechanism: Sales made as "at-the-market distributions" at the prevailing market price at the time of sale (prices may vary among purchasers and over time).
• Term: Effective until the earliest of:
  • July 12, 2028;
  • Issuance and sale of all Common Shares subject to the Distribution Agreement;
  • Receipt of notice from the British Columbia Securities Commission that the Base Shelf Prospectus has ceased to be effective; or
  • Termination of the Distribution Agreement.
• Use of Proceeds: Net proceeds, if any, are intended to fund ongoing operations. The Company may re-allocate proceeds based on strategy, market conditions, and industry landscape.
• Regulatory Basis: Established pursuant to a prospectus supplement dated June 29, 2026, to the Company's short form base shelf prospectus dated June 12, 2026.
• Previous Program: Follows a previous ATM program established in September 2025, which has since expired.
• Management Commentary: CFO Carlo Valente noted the program is a flexible tool to support the final stages of the Candiac scale-up and commercialization, complementing non-dilutive support from the Governments of Québec, Canada, and the US.

Notable Quotes

• "An at-the-market program is a flexible, cost-effective capital markets tool that can be used if and when appropriate," said Carlo Valente, Chief Financial Officer. "It complements the non-dilutive support previously announced from the Governments of Québec, Canada and the US while providing flexibility to support the final stages of our Candiac scale-up and the Company's commercialization efforts."